Acuracon Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 64.80%
- Profit Growth -0.54%
- Ebitda 44.50%
- Net Worth 75.49%
- Total Assets 207.80%
About Acuracon Health Sciences
Acuracon Health Sciences Private Limited (AHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 April 2018 (Six years and ten months 25 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kewal Bhambri, Urmil Bhambri, and Umang Bhambri serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190DL2018PTC332026
- Company No.
332026
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at Acuracon Health Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kewal Bhambri  | Director | 05-Apr-2018 | Current |
| Urmil Bhambri | Director | 05-Apr-2018 | Current |
| Umang Bhambri | Director | 05-Apr-2018 | Current |
Financial Performance of Acuracon Health Sciences.
Acuracon Health Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 64.8% increase. The company also saw a slight decrease in profitability, with a 0.54% decrease in profit. The company's net worth Soared by an impressive increase of 75.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acuracon Health Sciences?
In 2020, Acuracon Health Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dpderma India Private LimitedUmang Bhambri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acuracon Health Sciences?
Unlock and access historical data on people associated with Acuracon Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acuracon Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acuracon Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.